Sponsor:
University of Southern California
Code:
NCT04951726
Conditions
Ogilvie Syndrome
Eligibility Criteria
Sex: All
Age: 16+
Healthy Volunteers: Not accepted
Interventions
Neostigmine
Brief summary:
Conditions
Ogilvie Syndrome
Study ID
NCT04951726
Start date
Feb 4, 2022
Status verified date
Aug, 2023
Completion date
Aug 1, 2025
Anticipated
Primary completion date
Aug 1, 2025
Anticipated
Eligibility Criteria
Sex: All
Age: 16+
Healthy Volunteers: Not accepted
Enrollment
90 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
active comparator: IV push
experimental: subcutaneous
Interventions
Neostigmine
Primary outcome measure
Central contacts
Locations
Los Angeles University of Southern California Medical Center
Recruiting
Los Angeles, California, United States, 90004
Contacts
Sponsor
University of Southern California
Last update posted
Aug 25, 2023
Last verified
Aug, 2023
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Southern California on 2023-08-25.